Frontiers | Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
Relevance of placental type I interferon beta regulation for pregnancy success | Cellular & Molecular Immunology
Interferon type I - Wikipedia
Human IFN-κ Inhibited Respiratory RNA Virus Replication Dependent on Cell-to-Cell Interaction in the Early Phase | Infectious Diseases & Immunity
NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways: Cell
Frontiers | Type-I Interferons in Alzheimer's Disease and Other Tauopathies
IJMS | Free Full-Text | Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID
GeneCopoeia: IFN alpha signaling pathway
The Overview of Interferon-CUSABIO
Pathways of interferon receptor, inhibitor of nuclear factor kappa-B... | Download Scientific Diagram
Interferons | Bio-Techne
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Frontiers | Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
IJMS | Free Full-Text | Immunomodulatory Role of Interferons in Viral and Bacterial Infections
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies | PNAS
Interferons Research Area: R&D Systems
Anti-hIFN beta monoclonal antibody | InvivoGen
Interferons Research Area: R&D Systems
Emerging concepts of type I interferons in SLE pathogenesis and therapy | Nature Reviews Rheumatology
Single-cell analysis of signalling and transcriptional responses to type I interferons | bioRxiv
Role of IFN secretion during HIV-1 infection. The presence of HIV RNA... | Download Scientific Diagram
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology
How cancer cells make and respond to interferon-I: Trends in Cancer
Frontiers | Evasion of interferon-mediated immune response by arteriviruses
An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine
